NYSE$OSCR

Oscar Health Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Oscar Health's Q4 2021 performance was strong, meeting or exceeding expectations across key metrics, driven by historic growth during Open Enrollment.

Oscar Health, Inc. announced its financial results for the fourth quarter and year ended December 31, 2021. The company had a strong performance in Q4 2021, meeting or exceeding expectations across key metrics. Membership as of December 31, 2021 was 598,169, a 49% increase YoY.

  • Membership as of December 31, 2021 of 598,169, a 49% increase YoY
  • Direct and assumed premiums for 2021 were $3,437 million, a 50% increase YoY
  • Premiums earned for 2021 increased 302% YoY, driven by membership growth and lower quota share cession rates in 2021 compared to 2020.
  • Reaffirming 2022 outlook, including direct and assumed policy premiums of $6.1 - $6.4 billion, which would represent a more than 80% YoY increase, at the midpoint

Headline financials

Total Revenue

$496M

Previous: $158M+214.6%
EPS (adj)

-$0.95

Previous: -$35.41+97.3%
Medical loss ratio

97.9%

Previous: 107.9%-9.3%
Net Income

-$198M

Previous: -$190M-4.1%
Operating Income

-$196M

Previous: -$187M-5.0%
Gross Profit

$520M

Previous: $188M+177.3%
Cash & Equivalents

$1.1B

Previous: $826M+33.6%
Total Assets

$3.32B

Previous: $2.27B+46.2%
Stock-Based Comp

$28.3M

Previous: $13.9M+103.6%

Revenue & EPS history

Oscar Health · Revenue · Quarterly

$496M

Q4 2021+214.6%vs Q4 2020
Beat estimate in 3 of 11 quarters(27%)
ActualEstimate

Forward guidance

Oscar is reaffirming its 2022 outlook across all metrics, including direct and assumed policy premiums of $6.1 billion - $6.4 billion, an increase of more than 80% YoY, at the midpoint, and InsuranceCo Combined Ratio of 104% - 106%, an improvement of 570 bps, at the midpoint.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+3.7%

Avg return

Earnings day

+5.6%

Avg return

5 days after

+7.5%

Avg return

30 days after

64%

16 / 25 earnings

Positive

+30.0%

Q1 2025

Best reaction

-23.9%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.7%+22.6%+36.6%
Q4 2025+1.7%+6.0%+2.7%
Q3 2025-2.8%-12.8%-1.5%
Q1 2025+30.0%+28.7%+18.0%
Q4 2024+3.1%-3.7%+4.5%
Q3 2024-12.9%-12.8%+0.4%
Q2 2024+7.2%+4.4%-1.4%
Q1 2024+9.3%+14.1%+2.8%
Q4 2023+22.7%+27.5%+7.7%
Q3 2023+23.5%+24.5%+42.0%
Q2 2023+8.6%+1.9%-10.5%
Q1 2023-8.8%-6.6%+17.8%
Q4 2022+21.0%+36.2%-3.9%
Q3 2022-23.9%-4.5%-11.3%
Q2 2022+19.9%+21.1%-3.7%
Q1 2022-8.9%-2.0%-25.0%
Q4 2019+6.3%+2.5%+39.1%
Q4 2021+2.4%+15.6%+21.9%
Q3 2020-2.4%-6.3%-12.7%
Q3 2021-23.3%-25.2%-33.0%
Q2 2020-16.4%-11.8%+19.4%
Q2 2021-0.9%-12.0%+17.9%
Q4 2020+15.2%+14.5%+23.1%
Q1 2020+15.2%+14.5%+23.1%
Q1 2021+3.6%+4.2%+14.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro